Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Collins R., Keech A., Peto R., Sleight P., Kjekshus J., Wilhelmsen L., MacMahon S., Shaw J., Simes J., Braunwald E. Cholesterol and total mortality: need for larger trials. BMJ. 1992 Jun 27;304(6843):1689–1689. doi: 10.1136/bmj.304.6843.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furberg C. D., Adams H. P., Jr, Applegate W. B., Byington R. P., Espeland M. A., Hartwell T., Hunninghake D. B., Lefkowitz D. S., Probstfield J., Riley W. A. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation. 1994 Oct;90(4):1679–1687. doi: 10.1161/01.cir.90.4.1679. [DOI] [PubMed] [Google Scholar]
- Furberg C. D., Byington R. P., Crouse J. R., Espeland M. A. Pravastatin, lipids, and major coronary events. Am J Cardiol. 1994 Jun 1;73(15):1133–1134. doi: 10.1016/0002-9149(94)90297-6. [DOI] [PubMed] [Google Scholar]
- Oliver M. F. Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet. 1991 Jun 22;337(8756):1529–1531. doi: 10.1016/0140-6736(91)93208-q. [DOI] [PubMed] [Google Scholar]
- Pyörälä K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994 Oct;15(10):1300–1331. doi: 10.1093/oxfordjournals.eurheartj.a060388. [DOI] [PubMed] [Google Scholar]
- Rossouw J. E., Lewis B., Rifkind B. M. The value of lowering cholesterol after myocardial infarction. N Engl J Med. 1990 Oct 18;323(16):1112–1119. doi: 10.1056/NEJM199010183231606. [DOI] [PubMed] [Google Scholar]
- Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waters D., Higginson L., Gladstone P., Kimball B., Le May M., Boccuzzi S. J., Lespérance J. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation. 1994 Mar;89(3):959–968. doi: 10.1161/01.cir.89.3.959. [DOI] [PubMed] [Google Scholar]